Patents Assigned to Fractales Biotech
  • Patent number: 6426068
    Abstract: The invention concerns novel therapeutic uses of heterologous superoxide dismutase (HSD) for preparing medicines for treating diseases in which cell and organic degeneration is observed, and a method for selecting said HSD.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: July 30, 2002
    Assignee: Fractales Biotech
    Inventors: Bernard Dugas, Alphonse Calenda, Jacques Sauzieres, Eric Postaire